User login
SAN DIEGO – Patch testing may be in order for some patients with atopic dermatitis, according to Jonathan Silverberg, MD, PhD, of the department of dermatology, Northwestern University, Chicago.
Allergic contact dermatitis is a common comorbid condition in people with AD “and sometimes, can flare up the severity of the disease,” he said in a video interview at the American Academy of Dermatology annual meeting.
Patch testing can ferret out a trigger in atopic dermatitis patients with atypical disease distribution or refractory disease, and help avoid the need for systemic therapy, Dr. Silverman pointed out.
In the interview, he discussed these and other clinical scenarios, as well as how patch testing differs in these patients and what screening series to consider using.
Dr. Silverberg had no relevant financial disclosures.
SOURCE: Silverberg, J. et al, Session 061.
SAN DIEGO – Patch testing may be in order for some patients with atopic dermatitis, according to Jonathan Silverberg, MD, PhD, of the department of dermatology, Northwestern University, Chicago.
Allergic contact dermatitis is a common comorbid condition in people with AD “and sometimes, can flare up the severity of the disease,” he said in a video interview at the American Academy of Dermatology annual meeting.
Patch testing can ferret out a trigger in atopic dermatitis patients with atypical disease distribution or refractory disease, and help avoid the need for systemic therapy, Dr. Silverman pointed out.
In the interview, he discussed these and other clinical scenarios, as well as how patch testing differs in these patients and what screening series to consider using.
Dr. Silverberg had no relevant financial disclosures.
SOURCE: Silverberg, J. et al, Session 061.
SAN DIEGO – Patch testing may be in order for some patients with atopic dermatitis, according to Jonathan Silverberg, MD, PhD, of the department of dermatology, Northwestern University, Chicago.
Allergic contact dermatitis is a common comorbid condition in people with AD “and sometimes, can flare up the severity of the disease,” he said in a video interview at the American Academy of Dermatology annual meeting.
Patch testing can ferret out a trigger in atopic dermatitis patients with atypical disease distribution or refractory disease, and help avoid the need for systemic therapy, Dr. Silverman pointed out.
In the interview, he discussed these and other clinical scenarios, as well as how patch testing differs in these patients and what screening series to consider using.
Dr. Silverberg had no relevant financial disclosures.
SOURCE: Silverberg, J. et al, Session 061.
REPORTING FROM AAD 18
